Victrex Valuation

Is VCT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of VCT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: VCT (£8.81) is trading below our estimate of fair value (£19.45)

Significantly Below Fair Value: VCT is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for VCT?

Other financial metrics that can be useful for relative valuation.

VCT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.9x
Enterprise Value/EBITDA9.7x
PEG Ratio0.7x

Price to Earnings Ratio vs Peers

How does VCT's PE Ratio compare to its peers?

The above table shows the PE ratio for VCT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.3x
TET Treatt
27.2x15.3%UK£307.3m
JMAT Johnson Matthey
24.2x28.4%UK£2.6b
CRDA Croda International
32.4x16.0%UK£5.3b
IOF Iofina
13.4xn/aUK£37.4m
VCT Victrex
25x37.8%UK£766.1m

Price-To-Earnings vs Peers: VCT is expensive based on its Price-To-Earnings Ratio (25x) compared to the peer average (24.3x).


Price to Earnings Ratio vs Industry

How does VCT's PE Ratio compare vs other companies in the European Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a27.7%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a27.7%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: VCT is expensive based on its Price-To-Earnings Ratio (25x) compared to the European Chemicals industry average (17.8x).


Price to Earnings Ratio vs Fair Ratio

What is VCT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VCT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio25x
Fair PE Ratio22.1x

Price-To-Earnings vs Fair Ratio: VCT is expensive based on its Price-To-Earnings Ratio (25x) compared to the estimated Fair Price-To-Earnings Ratio (22.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst VCT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUK£8.81
UK£12.86
+46.0%
17.8%UK£16.80UK£8.50n/a12
Oct ’25UK£9.64
UK£13.16
+36.5%
14.8%UK£16.80UK£10.00n/a12
Sep ’25UK£10.30
UK£13.16
+27.8%
14.8%UK£16.80UK£10.00n/a12
Aug ’25UK£10.88
UK£13.77
+26.6%
12.7%UK£16.80UK£11.50n/a12
Jul ’25UK£11.22
UK£14.22
+26.7%
12.2%UK£17.50UK£11.50n/a12
Jun ’25UK£12.88
UK£14.75
+14.5%
13.8%UK£18.00UK£11.50n/a12
May ’25UK£12.60
UK£15.13
+20.1%
13.3%UK£18.00UK£11.90n/a12
Apr ’25UK£12.99
UK£15.25
+17.4%
14.8%UK£18.30UK£11.90n/a11
Mar ’25UK£12.97
UK£15.21
+17.3%
14.2%UK£18.30UK£11.90n/a12
Feb ’25UK£13.70
UK£15.61
+13.9%
13.2%UK£18.30UK£11.90n/a12
Jan ’25UK£15.22
UK£16.49
+8.4%
14.6%UK£20.90UK£12.50n/a13
Dec ’24UK£14.63
UK£16.55
+13.2%
14.2%UK£20.90UK£12.50n/a13
Nov ’24UK£13.76
UK£16.48
+19.7%
14.5%UK£20.90UK£12.50UK£8.8113
Oct ’24UK£14.05
UK£17.07
+21.5%
13.9%UK£21.00UK£13.30UK£9.6414
Sep ’24UK£15.05
UK£17.24
+14.6%
13.0%UK£21.00UK£13.30UK£10.3014
Aug ’24UK£15.16
UK£17.31
+14.2%
12.8%UK£21.00UK£13.30UK£10.8814
Jul ’24UK£13.92
UK£17.59
+26.3%
12.8%UK£21.00UK£14.50UK£11.2214
Jun ’24UK£15.67
UK£18.94
+20.8%
14.7%UK£23.00UK£14.50UK£12.8814
May ’24UK£16.76
UK£19.74
+17.8%
12.9%UK£23.00UK£15.20UK£12.6014
Apr ’24UK£15.93
UK£20.05
+25.9%
12.6%UK£23.10UK£15.20UK£12.9915
Mar ’24UK£17.61
UK£20.15
+14.4%
11.9%UK£23.10UK£16.00UK£12.9715
Feb ’24UK£18.51
UK£20.24
+9.3%
10.5%UK£23.00UK£16.00UK£13.7015
Jan ’24UK£15.97
UK£20.21
+26.6%
10.6%UK£23.00UK£16.00UK£15.2215
Dec ’23UK£17.99
UK£20.87
+16.0%
13.5%UK£27.35UK£16.00UK£14.6315
Nov ’23UK£16.82
UK£20.87
+24.1%
13.5%UK£27.35UK£16.00UK£13.7615

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies